Enoxaparin FDA Link Generic

Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)

Also Known As:

Lovenox; Clexane; EMT-966; EMT-967; Enoxaparine; PK-10,169; PK-10169; EMT 966; EMT 967; EMT966; EMT967; PK 10,169; PK 10169; PK10,169; PK10169

Pharmalogical Action Categories:

Anticoagulants
Fibrinolytic Agents

Carbohydrates: 22516
- Polysaccharides: 15996
  - Glycosaminoglycans: 5709
    - Heparin: 25261
      - Low-Molecular-Weight Heparin: 6739
        Enoxaparin: 3036

C H Davis Selected Research

C H Davis Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure